Pillar Biosciences
PrivateLast Round
Strategic
May 27, 2025
Total Funding Raised
$102.2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Pillar Biosciences is a biotechnology company that develops and manufactures targeted next-generation sequencing (NGS) panels and bioinformatics software for clinical cancer diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pillar Biosciences Comparables
Compare Pillar Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Paragon Genomics | 83% | |
| EntroGen, Inc. | 80% | |
| Labcorp | 76% |
Pillar Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | May 27, 2025 | ||||
| Series D | May 1, 2021 | ||||
| Series C | May 12, 2020 | ||||
| Series B | Nov 1, 2018 | ||||
| Series A | May 11, 2016 |
Pillar Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HB Ventures | Series C |
| Soleus Capital | Strategic |
| ORI Capital | Series A, Series C |
| Infinity Group | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors grew 46% MoM, reaching 4.4K.
- Apr 2, 2026
Partnered with CellCarta for global tumor profiling.
Recent news
Latest coverage and updates
- hiresSep 3, 2026
Pillar Biosciences, Inc. hired Todd Christian as Board of Directors on Sep 3rd '26.
- hiresSep 3, 2026
Pillar Biosciences, Inc. hired Yann Echelard as Board of Directors on Sep 3rd '26.
- hiresSep 3, 2026
Pillar Biosciences, Inc. hired Yann as Board of Directors on Jul 31st '26.
- hiresSep 3, 2026
Pillar Biosciences, Inc. hired Todd as Board of Directors on Jul 31st '26.
- launchesAug 27, 2026
Pillar Biosciences, Inc. launched automated NGS library preparation method on Aug 27th '26.
Pillar Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Pillar Biosciences's valuation, stock price, and market status.
Is Pillar Biosciences a public or private company?
Pillar Biosciences is a private company.
What is the current stock price of Pillar Biosciences?
Pillar Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is Pillar Biosciences worth (valuation)?
Valuation information for Pillar Biosciences is not publicly available.
Can I buy Pillar Biosciences stock?
Pillar Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Pillar Biosciences's last funding round?
Pillar Biosciences's most recent funding round was Strategic on May 27, 2025.
Who are the main investors in Pillar Biosciences?
Key investors in Pillar Biosciences include ORI Capital.
Will Pillar Biosciences IPO soon?
No public IPO plans have been announced for Pillar Biosciences.
How can I track Pillar Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pillar Biosciences's secondary market activity and sign up for updates.